Bridging Discovery to Clinic: How AI and Digital Technologies Are Transforming Therapeutics
Bridging Discovery to Clinic: How AI and Digital Technologies Are Transforming Therapeutics
Discover how technology is transforming therapeutics, reducing time-to-market, and cutting development costs.
We are entering a new era where artificial intelligence, digital technology, and next-generation engineering are converging to reshape the entire therapeutic lifecycle — from discovery and design to development, trials, manufacturing, and patient delivery.
This convergence is redefining how quickly and affordably treatments reach patients, marking a pivotal shift in efficiency, precision, and innovation velocity across life sciences. It is no surprise that capital allocation is concentrating in fewer, later-stage deals, with AI-driven discovery remaining a key investment bright spot. Join us for an afternoon panel discussion exploring how promising, high-impact companies are leveraging technology to reimagine the therapeutic lifecycle through AI, data, and digital integration.
Mixer and Panel Discussion
Co-hosted by Swartz Center for Entrepreneurship and the Pittsburgh Life Sciences Alliance
Sunday, January 11, 2026
2-4 PM (PT)
Obvious Ventures | 190 Pacific Ave, San Francisco, CA 94111
RSVP requested by Jan 2. Check back often for speaker updates.